Trial in progress: VALO study evaluating PTX-022 in adults with moderate-to-severe pachyonychia congenita, a rare, chronically debilitating disease that makes walking difficult or impossible Teng, J., Shroot, B., Evans, H., Schwartz, J., Connor, J., Valentine, J., Hansen, C. ELSEVIER SCIENCE INC. 2020: S68

View details for Web of Science ID 000554564400447